These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38231301)

  • 1. The Systemic Immune-Inflammation Index (SII) and coronary artery lesions in Kawasaki disease.
    Huang T; Peng Q; Zhang Y; Zhu Z; Fan X
    Clin Exp Med; 2024 Jan; 24(1):4. PubMed ID: 38231301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is There a Role for Laboratory Parameters in Predicting Coronary Artery Involvement in Kawasaki Disease?
    Yalcinkaya R; Öz FN; Durmuş SY; Fettah A; Kaman A; Teke TA; Örün UA; Tanır G
    Klin Padiatr; 2022 Nov; 234(6):382-387. PubMed ID: 35785802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between adropin and coronary artery lesions in children with Kawasaki disease.
    Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q
    Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki disease coronary artery lesions prediction with monocyte-to-high-density lipoprotein ratio.
    Yang C; Yang Y; Cao S; Ma Z; Du H; Li J; Dou F; Zhao Y; Li X; Hu X
    Pediatr Res; 2023 Jul; 94(1):246-251. PubMed ID: 36446921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
    Shuai S; Zhang H; Zhang R; Tang M; Luo E; Yang Y; Gao Y; Yue S; Liang H; Cai J
    J Pediatr (Rio J); 2023; 99(4):406-412. PubMed ID: 36977496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AST-to-ALT ratio and coronary artery lesions among patients with Kawasaki disease.
    Cao L; Tang YJ; Gang M; Ma J; Qian WG; Xu QQ; Lv HT
    World J Pediatr; 2021 Dec; 17(6):659-668. PubMed ID: 34792780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease.
    Ming L; Cao HL; Li Q; Yu G
    Pediatr Cardiol; 2021 Oct; 42(7):1496-1503. PubMed ID: 34036412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
    Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J; Liu P; Hu W; Xu Y; Deng J
    Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
    Wu Y; Wang S; Zhou Y; Yang Y; Li S; Yin W; Ding Y
    PLoS One; 2023; 18(10):e0292653. PubMed ID: 37824465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions.
    Wang L; Yang Y; Cui Q; Cui Y; Li Q; Che X; Wang C; Quan P; Hu X
    J Investig Med; 2021 Jan; 69(1):13-19. PubMed ID: 33004469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease.
    Wang N; Gao Y; Wang Y; Dai Y; Tang Y; Huang J; Sun L; Qian G; Ma J; Li X; Liu Y; Yang D; Huang X; Wang W; Li W; Zhuo W; Lv H; Liu Z
    Int Immunopharmacol; 2024 Sep; 139():112698. PubMed ID: 39029232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y
    Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Clin Rheumatol; 2022 Jan; 41(1):137-145. PubMed ID: 34363547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease.
    Chen Y; Yang M; Zhang M; Wang H; Zheng Y; Sun R; Li X
    Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):866-882. PubMed ID: 38357816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
    Chen YL; Wang JL; Li WQ
    Eur J Pediatr; 2014 Nov; 173(11):1467-71. PubMed ID: 24889335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.
    Ae R; Abrams JY; Maddox RA; Schonberger LB; Nakamura Y; Kuwabara M; Makino N; Matsubara Y; Matsubara D; Kosami K; Sasahara T; Belay ED
    Am Heart J; 2020 Jul; 225():120-128. PubMed ID: 32497905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A; Pal P; Basu S
    Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.